openPR Logo
Press release

Organ Transplant Immunosuppressant Market Will See Strong Expansion through 2020-2025 | Top Key Company's - Roche, Astellas Pharma, Novartis, Catalent Pharma, Cinkate, Cilag, Genzyme

04-15-2020 05:02 AM CET | Health & Medicine

Press release from: Business Industry Reports

Organ Transplant Immunosuppressant Market

Organ Transplant Immunosuppressant Market

Overview of Global Organ Transplant Immunosuppressant Market:

This report provides in-depth study of "Global Organ Transplant Immunosuppressant Market 2020" using SWOT analysis i.e. Strength, Weakness, Opportunities, and Threat to the organization. The Organ Transplant Immunosuppressant Market report also provides an in-depth survey of key players in the market organization.

According to the market research study, the organ transplantation is surgical procedure that involves replacing diseased organs such as a heart, liver, kidney, or lung with healthy organs. The donor organ can come from a deceased donor such as in heart transplants, or kidney, liver, and rarely lung transplants from living donors. As per the Centers for Disease Control and Prevention (CDC) analysis report, the most commonly transplanted organs in the US are the kidney, liver, heart, lungs, pancreas, and intestine. On any given day, there are about 75,000 people on active waiting list for organ transplantation.

Available Exclusive Sample Copy of this Report @ https://www.businessindustryreports.com/sample-request/258574 .

In terms of the regional analysis, North America represents developed regional market for Organ Transplant Immunosuppressant. Presence of favorable reimbursement policies, presence of developed healthcare facilities, technological advancements, increasing healthcare spending are major factors driving the market growth in this region. Europe was second largest market in 2018. APAC is projected to witness rapid CAGR for Organ Transplant Immunosuppressant Market. Dense population base, increasing chronic disease burden, increasing healthcare expenditure, introduction of favorable reimbursement policies are expected to boost market growth in APAC.

Through the statistical analysis, the report depicts the international Organ Transplant Immunosuppressant Market including capacity, production, production value, cost/profit, supply/demand and global import/export. The total market is further divided by company, by country, and by application/type for the competitive landscape analysis. The report then estimates 2020-2025 market development trends of Organ Transplant Immunosuppressant industry. Analysis of upstream raw materials, downstream demand, and current market dynamics is also carried out.

Global Key Vendors:

1 Roche

2 Astellas Pharma Inc.

3 Huadong Pharmaceutical

4 Novartis

5 Catalent Pharma

6 Cinkate Corporation

7 Cilag

8 Genzyme

9 Changzhou Pharm

10 North China Pharmaceutical Group Corporation

11 SL PHARM

12 Livzon Pharmaceutical Group Inc.,

13 Sirio Pharma Co., Ltd and More.....................

Purchase this report online with 90 Pages, List of Tables & Figures and in-depth Table of Contents on "Global Organ Transplant Immunosuppressant Market Report 2020" @ https://www.businessindustryreports.com/buy-now/258574/single .

Product Type Segmentation

1 Tacrolimus

2 Mycophenolate Mofetil

3 Cyclosporin

4 Others

Industry Segmentation

1 Liver Transplant

2 Kidney Transplant

3 Heart Transplant

4 Other Organ Transplant

Top Medical Industry News:

Roche (April 07, 2020) - Roche provides regulatory update on risdiplam for the treatment of spinal muscular atrophy (SMA) - Roche, today announced that the U.S. Food and Drug Administration (FDA) has extended the Prescription Drug User Fee Act (PDUFA) date for its review of the New Drug Application (NDA) of risdiplam with a decision expected by August 24, 2020. The extension is a result of the recent submission of additional data by Roche, including data from the pivotal SUNFISH Part 2 study, in close collaboration with the FDA. These data were recently presented at the 2nd International Scientific and Clinical Congress on Spinal Muscular Atrophy.

In November 2019, the FDA granted Priority Review for risdiplam with a decision for approval expected by May 24, 2020. In February 2020, based on discussions with the FDA, Roche submitted additional data which could help ensure access to risdiplam for a broad range of people living with the condition, if approved. This included 12-month efficacy and safety data from the pivotal SUNFISH Part 2 study (n=180), the only placebo-controlled study ever undertaken in people aged 2-25 years with Type 2 or 3 SMA. Given the volume of additional data submitted, the FDA requires more time for review.

"We strongly believe in the potential of risdiplam as a new therapeutic option and recognize that unmet need remains in the treatment of SMA," said Levi Garraway, M.D., Ph.D., chief medical officer and head of Global Product Development. "We are working closely with the FDA to support the review of risdiplam. Our goal is to bring this therapy to infants, children and adults living with SMA as quickly as possible."

As part of our continued commitment to people living with SMA, Roche is pleased to announce that we have also submitted in Brazil, Chile, Indonesia, Russia, South Korea and Taiwan. Filing in China is imminent and we are currently on track to submit a Marketing Authorization Application (MAA) to the European Medicines Agency in mid-2020 as well as other international markets.

Grab Your Report at an Impressive Discount @ https://www.businessindustryreports.com/check-discount/258574 .

Major Points in Table of Contents:

Global Organ Transplant Immunosuppressant Market Report 2020

1 Organ Transplant Immunosuppressant Product Definition

2 Global Organ Transplant Immunosuppressant Market Manufacturer Share and Market Overview

3 Manufacturer Organ Transplant Immunosuppressant Business Introduction

4 Global Organ Transplant Immunosuppressant Market Segmentation (Region Level)

5 Global Organ Transplant Immunosuppressant Market Segmentation (Product Type Level)

6 Global Organ Transplant Immunosuppressant Market Segmentation (Industry Level)

7 Global Organ Transplant Immunosuppressant Market Segmentation (Channel Level)

8 Organ Transplant Immunosuppressant Market Forecast 2020-2025

9 Organ Transplant Immunosuppressant Segmentation Product Type

10 Organ Transplant Immunosuppressant Segmentation Industry

11 Organ Transplant Immunosuppressant Cost of Production Analysis

12 Conclusion

................... Request free sample to get a complete Table of Content

About us

BusinessindustryReports.com is digital database of comprehensive market reports for global industries. As a market research company, we take pride in equipping our clients with insights and data that holds the power to truly make a difference to their business. Our mission is singular and well-defined - we want to help our clients envisage their business environment so that they are able to make informed, strategic and therefore successful decisions for themselves.

Media Contact

Business Industry Reports

Pune - India

sales@businessindustryreports.com

+19376349940

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Organ Transplant Immunosuppressant Market Will See Strong Expansion through 2020-2025 | Top Key Company's - Roche, Astellas Pharma, Novartis, Catalent Pharma, Cinkate, Cilag, Genzyme here

News-ID: 2010783 • Views: 894

More Releases from Business Industry Reports

Tetracaine Market Exhibits a Lucrative Growth Potential during 2021-2025 | Endo …
BusinessIndustryReports has recently broadcasted a new study to its broad research portfolio, which is titled as “Global Tetracaine Market” Research Report 2021 provides an in-depth analysis of the Tetracaine with the forecast of market size and growth. The analysis includes addressable market, market by volume, market share by business type and by segment (external and in-house). The research study examines the Tetracaine on the basis of a number of criteria,
Cyber Warfare Market Evenly Poised To Reach A Market Value of US$ By Share, Size …
Overview of Global Cyber Warfare Market: This report provides in-depth study of “Global Cyber Warfare Market 2021” using SWOT analysis i.e. Strength, Weakness, Opportunities, and Threat to the organization. The Cyber Warfare Market report also provides an in-depth survey of key players in the market organization. According to the market research study, the Cyber Warfare is virtual conflict between state, organization, or country by the use of computer technology to disrupt activities
Covid-19 Impact on Cranio Maxillofacial Implant Market 2021-2025: Business Growt …
Overview of Global Cranio Maxillofacial Implant Market: This report provides in-depth study of “Global Cranio Maxillofacial Implant Market 2021” using SWOT analysis i.e. Strength, Weakness, Opportunities, and Threat to the organization. The Cranio Maxillofacial Implant Market report also provides an in-depth survey of key players in the market organization. According to the market research study, Craniomaxillofacial Implants are medical implants used in surgeries of maxillofacial region such as, head, face, neck, oral,
Beginning of the bloom: The Rise of the Biohacking Market 2021-2025 | Global Key …
Global Biohacking Market Synopsis: The report covers a forecast and an analysis of the Biohacking Market on a global and regional level. The study provides historical data for 2015, 2016, 2017 and 2018 along with a forecast from 2020 to 2025 based on revenue (USD Million) and volume (Kilotons). The study includes drivers and restraints of the Biohacking Market along with the impact they have on the demand over the forecast

All 5 Releases


More Releases for Transplant

Transplant Diagnostics Market
Transplant diagnostics is the examination of factors associated with recently performed transplant. This can be elaborated as safety testing, compatibility, testing, transplant feasibility testing, pre, peri, and post transplantation. This is done to check the tissue compatibility between the donor and patient in organ transplant. Major Players: The prominent players in the transplant diagnostics market are Bio-Rad Laboratories, Inc., Thermo Fisher Scientific Inc., QIAGEN, F. Hoffmann-La Roche Ltd., Illumina, Inc., Merck KGaA,
hair transplant services
Hair transplant is a surgical procedures that moves hair follicles from one part of the body to another part of the body. Hair transplantation is chiefly used to treat the baldness in male and female. The global hair transplant services market is witnessing a rise in its demand. The market is segmented into three major transplant procedures like scalp reduction, follicular unit strip surgery and follicular unit extraction. Increasing importance regarding
Europe Transplant Diagnostics Market
The Europe Transplant Diagnostics Market Report is an upcoming report from Data Bridge Market Research. The new market report contains data for historic years 2015, the base year of calculation is 2017 and the forecast period is 2018 to 2025. Transplant diagnostics are the diagnostics tests performed while relocating organ in order to treat organ failure such as liver, pancreas, lungs, kidney, and heart. These tests are widely performed by skilled
Hair Transplant in Turkey
Istanbul is not only recognised with its world-famous Bosphorus Bridge any more. It is the first city comes to mind in hair transplant operations globally. Moreover, one in every five people in the world travels to Istanbul for medical tourism to undergo a hair transplant procedure. If you surf the internet and use search engines, you will come across with an enormous number of advertisements, clinics, hospitals, doctors and even
Transplant Diagnostics Market : Market and Growth Analysis
Global Transplant Diagnostics Market: Competitive Landscape The report profiles some of the prominent competitors operating in the market. It also provides insights into the challenges and opportunities that the companies are projected to witness in the coming years. Some of the players in the global transplant diagnostics market are Thermo Fisher Scientific Inc., Illumina, Inc., F. Hoffman-La Roche Ltd., QIAGEN N.V., Immucor, Inc., bioMérieux S.A., Bio-Rad Laboratories, Inc., Becton Dickinson and
Global Transplant Diagnostics Market Research Report 2016
2016 Global Transplant Diagnostics Industry Report is a professional and in-depth research report on the world’s major regional market conditions of the Transplant Diagnostics industry, focusing on the main regions (North America, Europe and Asia) and the main countries (United States, Germany, Japan and China). The report firstly introduced the Transplant Diagnostics basics: definitions, classifications, applications and industry chain overview; industry policies and plans; product specifications; manufacturing processes; cost structures and